AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Company updates positive clinical data on multiple antisense drugs.
2003 DEC 4 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced positive data from clinical trials of four antisense drugs for the treatment of four diseases.
Final results from phase II studies of ISIS 104838 in patients with rheumatoid arthritis and ISIS 14803 for the treatment of the hepatitis C virus (HCV) were presented at the 67th annual meeting of the American College of Rheumatology and the 54th annual meeting of the American Association for the Study of Liver Diseases, respectively.
Updated results of a phase II study of alicaforsen (ISIS 2302) in patients with pouchitis were presented at the 67th annual scientific meeting of the American College of Gastroenterology, and results from a phase I study involving ISIS 113715 for type 2 diabetes were reported at the Nucleic Acid World Summit in September.
"The recent positive results from multiple drugs in a variety of diseases demonstrate antisense technology's broad applicability, and add to the growing body of evidence that antisense drugs are active in man," said Jon T. Holmlund, MD, Isis' vice ...
- Isis' novel second-generation antisense drugs continue to show promise Through...
- Newspaper article from: BIOTECH Patent News February 1, 2000 700+ words
...this publication, Isis scientists demonstrated that antisense drugs containing sugar...first generation antisense drugs. Currently, Isis has antisense inhibitors...more broadly useful antisense drugs." Isis is engaged in the...
- Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment...
- Press release article from: PR Newswire November 27, 2007 700+ words
...and develop antisense drugs for the local...scarring. Isis has granted...of certain antisense drugs. Excaliard...payment to Isis in the form...royalties on antisense drugs developed by Excaliard. "Isis has made superb...
- Isis and Elan Form Partnership to Develop Oral Antisense Drugs; TNF-alpha...
- Press release article from: PR Newswire April 12, 1999 700+ words
...oral delivery of antisense drugs. Isis will be the majority...subsidiary. Isis has made substantial...formulations of antisense drugs, achieving significant...Executive Officer, Isis Pharmaceuticals...oral delivery of antisense drugs will significantly...
- ISIS PUBLICATIONS DESCRIBE ADVANCES IN VALIDATING ANTISENSE MECHANISM OF ACTION...
- Press release article from: PR Newswire December 7, 1995 700+ words
...are being used by Isis to create antisense drugs that promise greater...Stanley T. Crooke, Isis Pharmaceuticals...in the design of antisense drugs with proven mechanism...improvements in antisense drugs." Isis Pharmaceuticals...
- Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and...
- Press release article from: PR Newswire June 9, 2009 700+ words
...PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. announced today that Isis' antisense drugs were highlighted with...data was presented from Isis' anti-obesity drug discovery program showing antisense drugs reduced fat mass and...
- Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly...
- Press release article from: PR Newswire October 16, 2007 700+ words
...development and commercialization of Isis' antisense drugs to treat asthma and other respiratory conditions. Isis has granted an exclusive worldwide...respiratory conditions to advance antisense drugs, including ISIS 369645," said Jeff Jonas...
- Isis Pharmaceuticals Announces Collaboration With Pfizer to Discover Antisense...
- Press release article from: PR Newswire May 24, 2005 700+ words
...second-generation antisense drugs for the treatment...the agreement, Isis will receive a technology...may develop the antisense drugs identified in the...indications. "Isis has already shown that antisense drugs can be effective...
- Isis' Partners Present Clinical Data on Antisense Drugs at the American Society...
- Press release article from: PR Newswire June 2, 2008 700+ words
...anticancer drugs discovered by Isis. In both presentations, antisense drugs being developed by Isis' partners OncoGenex and Lilly...Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases...
- Isis Pharmaceuticals Updates Positive Clinical Data on Multiple Antisense...
- Press release article from: PR Newswire October 27, 2003 700+ words
Isis Pharmaceuticals...trials of four antisense drugs for the treatment...evidence that antisense drugs are active...M.D., Isis' Vice President...challenge. Isis' proprietary...generation antisense drugs represent a...
- Isis highlights new data on antisense drugs to treat Type 2 diabetes and...
- News wire article from: Chemical Business Newsbase June 9, 2009 700+ words
Isis Pharmaceuticals Inc (Isis) announced that Isis' antisense drugs were highlighted with eight presentations (including three oral talks and two late-breaking posters) during the American Diabetes Association's (ADA) 69th Scientific...
Source: HighBeam Research, Company updates positive clinical data on multiple antisense drugs.